Publication | Closed Access

Colonic mucosa-specific “pro-antedrugs” for oral treatment of ulcerative colitis: design, synthesis and fate of methyl 20-glucopyranosyloxyprednisolonates

ProbioticMucosal ImmunologyGastrointestinal PharmacologyMedicineImmunologyGastroenterologyOral TreatmentGastrointestinal PathologyUlcerative ColitisPharmacologyMethyl 20-Glucopyranosyloxyprednisolonates